C12N2760/18532 - CPC Classification Index

ClassID:

110981 ⎘

C12N2760/18532 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Pneumovirus, e.g. human respiratory syncytial virus Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:

20230364147

2023-11-16

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

20200121784

2020-04-23

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

20190216855

2019-07-18

Method of targeting oncolytic viruses to tumors

20180207211

2018-07-26

Respiratory syncytial virus with a genomic deficiency complemented in trans

20170368166

2017-12-28

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

20160263209

2016-09-15

Tissue targeted antigenic activation of the immune response to treat cancers

20150343050

2015-12-03

Tissue targeted antigenic activation of the immune response to treat cancers

20150329833

2015-11-19

Respiratory syncytial virus with a genomic deficiency complemented in trans

20130251680

2013-09-26

Lung cancer therapy using an engineered respiratory syncytial virus

#10

20110195093

2011-08-11

Tissue targeted antigenic activation of the immune response to treat cancers

#11

20100303839

2010-12-02

Methods and compositions for treatment of cancer using oncolytic RSV activity

#12

20100291035

2010-11-18

Respiratory syncytial virus with a genomic deficiency complemented in trans

#13

13134543

2015-06-02

NS1/2-deficient respiratory syncytial virus and melanoma treatment

#14

13134326

2015-06-23

Prostate cancer therapy using an engineered respiratory syncytial virus